Mai Capital Management Vor Biopharma Inc. Call Options Transaction History
Mai Capital Management
- $13 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VOR
# of Institutions
45Shares Held
54.1MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA39.6MShares$7.53 Million0.59% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$1.21 Million3.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$368,6420.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$204,1850.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny701KShares$133,2710.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $7.23M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...